Cargando…

FGF21 functions as a sensitive biomarker of APAP-treated patients and mice

Acetaminophen (APAP) is a common medication that induces hepatocellular damage in a time- or dose-dependent manner. Fibroblast growth factor 21 (FGF21) exerts a series of biological effects, including cellular repair. Compared to clinical diagnosis parameters, we aimed to evaluate whether FGF21 can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Rong, Guo, Chao, Wu, Xinmou, Huang, Zhaoquan, Chen, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546492/ https://www.ncbi.nlm.nih.gov/pubmed/28591702 http://dx.doi.org/10.18632/oncotarget.17966

Ejemplares similares

The complex roles of neutrophils in APAP‐induced liver injury
por: Guo, Huiting, et al.
Publicado: (2021)

Downregulation of hepatic METTL3 contributes to APAP-induced liver injury in mice
por: Liu, Chunhong, et al.
Publicado: (2023)

Farrerol Ameliorates APAP-induced Hepatotoxicity via Activation of Nrf2 and Autophagy
por: Wang, Lidong, et al.
Publicado: (2019)

An exploratory study investigating biomarkers associated with autoimmune pulmonary alveolar proteinosis (aPAP)
por: Campo, Ilaria, et al.
Publicado: (2022)

Effect of Acetaminophen (APAP) on Physiological Indicators in Lactuca sativa
por: Kudrna, Jiri, et al.
Publicado: (2020)

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020)

FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
por: Henriksson, Emma, et al.
Publicado: (2020)

Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice
por: Yu, Youxi, et al.
Publicado: (2021)

FGF19 subfamily members: FGF19 and FGF21
por: Dolegowska, Katarzyna, et al.
Publicado: (2019)

Hepatoprotective Effect of Citrus aurantium L. Against APAP-induced Liver Injury by Regulating Liver Lipid Metabolism and Apoptosis
por: Shu, Yisong, et al.
Publicado: (2020)

Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
por: Aaldijk, Alexandra S., et al.
Publicado: (2023)

Analysis of Functional Promoter of Camel FGF21 Gene and Identification of Small Compounds Targeting FGF21 Protein
por: Yong, Fang, et al.
Publicado: (2023)

FGF21 Levels in Pheochromocytoma/Functional Paraganglioma
por: Klímová, Judita, et al.
Publicado: (2019)

FGF19 and FGF21: In NASH we trust
por: Talukdar, Saswata, et al.
Publicado: (2020)

Less may be more: CPAP vs. APAP in the treatment of obstructive sleep apnea
por: Perin, Christiano, et al.
Publicado: (2021)

Hepatocyte Specific gp130 Signalling Underlies APAP Induced Liver Injury
por: Dong, Jinrui, et al.
Publicado: (2022)

The potential function and clinical application of FGF21 in metabolic diseases
por: Chen, Zhiwei, et al.
Publicado: (2022)

Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice
por: Morovat, Alireza, et al.
Publicado: (2017)

Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer
por: Knott, ME, et al.
Publicado: (2016)

4-Hydroxyphenylacetic Acid Prevents Acute APAP-Induced Liver Injury by Increasing Phase II and Antioxidant Enzymes in Mice
por: Zhao, Hongqiong, et al.
Publicado: (2018)

Obesity-resistance of UCP1-deficient mice associates with sustained FGF21 sensitivity in inguinal adipose tissue
por: Klein Hazebroek, Marlou, et al.
Publicado: (2022)

Advances in Biological Functions and Clinical Studies of FGF21
por: Lin, Wei, et al.
Publicado: (2021)

FGF21 and Cardiac Physiopathology
por: Planavila, Anna, et al.
Publicado: (2015)

Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue
por: Villarroya, Joan, et al.
Publicado: (2018)

Improved FGF21 Sensitivity and Restored FGF21 Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats After Duodenal-Jejunal Bypass and Sleeve Gastrectomy
por: Liu, Qiaoran, et al.
Publicado: (2019)

Polystyrene Microplastics Postpone APAP-Induced Liver Injury through Impeding Macrophage Polarization
por: Liu, Jing, et al.
Publicado: (2022)

Synthesis of Chitosan Oligosaccharide-Loaded Glycyrrhetinic Acid Functionalized Mesoporous Silica Nanoparticles and In Vitro Verification of the Treatment of APAP-Induced Liver Injury
por: Guo, Xinghua, et al.
Publicado: (2023)

FGF21 regulates insulin sensitivity following long-term chronic stress
por: Jelenik, Tomas, et al.
Publicado: (2018)

Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid: Relationship With Plasma FGF21 and Body Adiposity
por: Tan, Bee K., et al.
Publicado: (2011)

Acute Exercise Induces FGF21 Expression in Mice and in Healthy Humans
por: Kim, Kook Hwan, et al.
Publicado: (2013)

Hepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in Mice
por: Ziros, Panos, et al.
Publicado: (2016)

Estradiol-dependent and independent effects of FGF21 in obese female mice
por: Jakovleva, T.V., et al.
Publicado: (2022)

FGF21 negatively affects long-term female fertility in mice
por: Moeckli, Beat, et al.
Publicado: (2022)

Fgf21 Impairs Adipocyte Insulin Sensitivity in Mice Fed a Low-Carbohydrate, High-Fat Ketogenic Diet
por: Murata, Yusuke, et al.
Publicado: (2013)

The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine
por: Burow, Philipp, et al.
Publicado: (2021)

In Pursuit of a Biomarker of Weight Gain Susceptibility—Is FGF21 a Candidate?
por: Redman, Leanne M., et al.
Publicado: (2019)

Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy
por: Ye, Hui, et al.
Publicado: (2022)

FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic Diseases
por: Kim, Kook Hwan, et al.
Publicado: (2014)

Modulation of HMGB1 Release in APAP-Induced Liver Injury: A Possible Strategy of Chikusetsusaponin V Targeting NETs Formation
por: Liu, Jian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nlcga6k6c8ruk087392pphahto